Viruses News and Research RSS Feed - Viruses News and Research

Free fatty acids may be effective in treating catheter-related bloodstream infections

Free fatty acids may be effective in treating catheter-related bloodstream infections

Researchers at Rhode Island Hospital, Veterans Affair Medical Center in Providence and University of Rhode Island have found that a free fatty acid, made up of compounds similar to those naturally made in the body, may be as effective at fighting certain infections as antibiotics. [More]
NASA study reveals how spaceflight affects immune system of crew members

NASA study reveals how spaceflight affects immune system of crew members

There is nothing like a head cold to make us feel a little dazed. We get things like colds and the flu because of changes in our immune system. Researchers have a good idea what causes immune system changes on Earth-think stress, inadequate sleep and improper nutrition. [More]
Innate lymphoid cells induce specific T and B cell responses during inflammation

Innate lymphoid cells induce specific T and B cell responses during inflammation

In case of an inflammation the body releases substances that increase the immune defense. During chronic inflammation, this immune response gets out of control and can induce organ damage. [More]
Globavir plans to seek approval, launch novel drug for treatment of Ebola infection

Globavir plans to seek approval, launch novel drug for treatment of Ebola infection

Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway. [More]
Aging Japanese population driving high CAP burden

Aging Japanese population driving high CAP burden

There is a high incidence of community-acquired pneumonia in Kochi City in western Japan, which is primarily explained by the large proportion of elderly inhabitants, researchers report. [More]
ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Immune Targeting Systems, specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (FlunisynTM) designed to protect humans from all strains of seasonal and pandemic influenza A. [More]
UI scientists discover that CF mucus abnormality is present at birth

UI scientists discover that CF mucus abnormality is present at birth

Mucus is key to keeping our lungs clean and clear of bacteria, viruses, and other foreign particles that can cause infection and inflammation. When we inhale microbes and dust, they are trapped in the mucus and then swept up and out of the lungs via a process called mucociliary transport. [More]
Researchers now have a clear picture of bacterial immune system

Researchers now have a clear picture of bacterial immune system

Bacteria's ability to destroy viruses has long puzzled scientists, but researchers at the Johns Hopkins Bloomberg School of Public Health say they now have a clear picture of the bacterial immune system and say its unique shape is likely why bacteria can so quickly recognize and destroy their assailants. [More]
Researchers reveal importance of highly specialised immune cells in killing melanoma cells

Researchers reveal importance of highly specialised immune cells in killing melanoma cells

Melbourne researchers have revealed the critical importance of highly specialised immune cells, called natural killer cells, in killing melanoma cells that have spread to the lungs. [More]
Ebola virus defeats attempts by interferon to block viral reproduction in infected cells

Ebola virus defeats attempts by interferon to block viral reproduction in infected cells

One of the human body's first responses to a viral infection is to make and release signaling proteins called interferons, which amplify the immune system response to viruses. [More]
Researchers identify mechanism used by deadly MERS virus to transmit from bats to humans

Researchers identify mechanism used by deadly MERS virus to transmit from bats to humans

Researchers have identified the mechanism used by the deadly MERS virus to transmit from bats to humans. Bats are a native reservoir for MERS and the finding could be critical for understanding the animal origins of the virus, as well as preventing and controlling the spread of MERS and related viruses in humans. [More]
Researchers discover how immunosensory system attacks viruses on a molecular level

Researchers discover how immunosensory system attacks viruses on a molecular level

Our immunosensory system detects virus such as influenza via specific characteristics of viral ribonucleic acid. Previously, it was unclear how the immune system prevents viruses from simply donning molecular camouflage in order to escape detection. [More]
Inovio Pharmaceuticals reports increased revenue in second quarter 2014

Inovio Pharmaceuticals reports increased revenue in second quarter 2014

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013. [More]
Oncolytics Biotech announces financial results and operational highlights for second quarter 2014

Oncolytics Biotech announces financial results and operational highlights for second quarter 2014

Oncolytics Biotech Inc. today announced its financial results and operational highlights for the second quarter ended June 30, 2014. [More]
New techniques offer insight into cell-by-cell makeup of organisms

New techniques offer insight into cell-by-cell makeup of organisms

In general, our knowledge of biology-and much of science in general-is limited by our ability to actually see things. Researchers who study developmental problems and disease, in particular, are often limited by their inability to look inside an organism to figure out exactly what went wrong and when. [More]
Cancer fighter may also help patients survive pneumonia

Cancer fighter may also help patients survive pneumonia

The tip of an immune molecule known for its skill at fighting cancer may also help patients survive pneumonia, scientists report. [More]
Laboratories at TSRI investigate antibodies to fight Ebola virus

Laboratories at TSRI investigate antibodies to fight Ebola virus

Laboratories at The Scripps Research Institute (TSRI) are investigating antibodies to fight Ebola virus, including the three antibodies recently used to treat two American health care workers infected with the Ebola virus. [More]

States of Maine and Rhode Island add SCID to newborn screening panels

The Immune Deficiency Foundation commends the states of Maine and Rhode Island for adding Severe Combined Immune Deficiency to their states' newborn screening panels, effective August 1, 2014. These states join 21 other states currently screening newborns for SCID, ensuring over two thirds of all babies in the U.S. are now being screened. [More]
Virologists find cells are having to fight virus constantly, even in dormant phase

Virologists find cells are having to fight virus constantly, even in dormant phase

Scientists investigating the herpes virus have been surprised to find an ongoing conflict in the cells of sufferers, even when the virus is apparently dormant. [More]
Viewpoints: Medicare's future finances; 'promising deal' on VA; Texas 'war on abortion'

Viewpoints: Medicare's future finances; 'promising deal' on VA; Texas 'war on abortion'

Medicare got some good news Monday, when the trustees who oversee its finances announced that the fund that pays for hospital care will remain solvent until 2030, four years longer than its forecast from last year. [More]